...
首页> 外文期刊>Pharmaceutical Research >Characterization of Hepatobiliary Transport Systems of a Novel α4β1/α4β7 Dual Antagonist, TR-14035
【24h】

Characterization of Hepatobiliary Transport Systems of a Novel α4β1/α4β7 Dual Antagonist, TR-14035

机译:新型α4β1/α4β7双重拮抗剂TR-14035的肝胆运输系统特性

获取原文
获取原文并翻译 | 示例
           

摘要

Our previous pharmacokinetic studies have demonstrated that TR-14035, a novel dual antagonist for α4β1/α4β7 integrin, selectively and strongly accumulated in the liver and was mainly excreted in bile as an unchanged drug. In the present study, we investigated the hepatobiliary transport system in detail.
机译:我们以前的药代动力学研究表明,TR-14035是α4β1/α4β7整联蛋白的新型双重拮抗剂,在肝脏中选择性而强烈地积聚,并作为未改变的药物主要在胆汁中排泄。在本研究中,我们详细研究了肝胆运输系统。

著录项

  • 来源
    《Pharmaceutical Research》 |2006年第11期|2646-2656|共11页
  • 作者单位

    Exploratory DMPK Exploratory Toxicology ampamp DMPK Research Laboratories Tanabe Seiyaku Co. Ltd. 2-2-50 Kawagishi Toda Saitama 335-8505 Japan;

    Faculty of Pharmaceutical Sciences Tokyo University of Science Chiba Japan;

    Faculty of Pharmaceutical Sciences Tokyo University of Science Chiba Japan;

    Exploratory DMPK Exploratory Toxicology ampamp DMPK Research Laboratories Tanabe Seiyaku Co. Ltd. 2-2-50 Kawagishi Toda Saitama 335-8505 Japan;

    Faculty of Pharmaceutical Sciences Tokyo University of Science Chiba Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    genetic polymorphism; hepatobiliary transport; MRP2; OATP;

    机译:遗传多态性;肝胆运输;MRP2;OATP;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号